PMID: 9261097

Loo TW, Clarke DM
Drug-stimulated ATPase activity of human P-glycoprotein requires movement between transmembrane segments 6 and 12.
J Biol Chem. 1997 Aug 22;272(34):20986-9., 1997-08-22 [PubMed]
Sentences
No. Mutations Sentence Comment
68 ABCB1 p.Gly346Cys
X
ABCB1 p.Gly346Cys 9261097:68:162
status: NEW
view ABCB1 p.Gly346Cys details
ABCB1 p.Gly989Cys
X
ABCB1 p.Gly989Cys 9261097:68:168
status: NEW
view ABCB1 p.Gly989Cys details
ABCB1 p.Pro350Cys
X
ABCB1 p.Pro350Cys 9261097:68:179
status: NEW
view ABCB1 p.Pro350Cys details
ABCB1 p.Ser993Cys
X
ABCB1 p.Ser993Cys 9261097:68:185
status: NEW
view ABCB1 p.Ser993Cys details
ABCB1 p.Leu339Cys
X
ABCB1 p.Leu339Cys 9261097:68:136
status: NEW
view ABCB1 p.Leu339Cys details
ABCB1 p.Phe343Cys
X
ABCB1 p.Phe343Cys 9261097:68:149
status: NEW
view ABCB1 p.Phe343Cys details
ABCB1 p.Val982Cys
X
ABCB1 p.Val982Cys 9261097:68:142
status: NEW
view ABCB1 p.Val982Cys details
ABCB1 p.Met986Cys
X
ABCB1 p.Met986Cys 9261097:68:155
status: NEW
view ABCB1 p.Met986Cys details
ABCB1 p.Phe336Cys
X
ABCB1 p.Phe336Cys 9261097:68:123
status: NEW
view ABCB1 p.Phe336Cys details
ABCB1 p.Ser979Cys
X
ABCB1 p.Ser979Cys 9261097:68:129
status: NEW
view ABCB1 p.Ser979Cys details
To test these predictions, we introduced pairs of cysteines into a Cys-less mutant of P-glycoprotein to create the mutants F336C/S979C, L339C/V982C, F343C/M986C, G346C/G989C, and P350C/S993C. Login to comment
76 ABCB1 p.Gly346Cys
X
ABCB1 p.Gly346Cys 9261097:76:106
status: NEW
view ABCB1 p.Gly346Cys details
ABCB1 p.Gly989Cys
X
ABCB1 p.Gly989Cys 9261097:76:112
status: NEW
view ABCB1 p.Gly989Cys details
ABCB1 p.Pro350Cys
X
ABCB1 p.Pro350Cys 9261097:76:123
status: NEW
view ABCB1 p.Pro350Cys details
ABCB1 p.Ser993Cys
X
ABCB1 p.Ser993Cys 9261097:76:130
status: NEW
view ABCB1 p.Ser993Cys details
ABCB1 p.Phe343Cys
X
ABCB1 p.Phe343Cys 9261097:76:93
status: NEW
view ABCB1 p.Phe343Cys details
ABCB1 p.Met986Cys
X
ABCB1 p.Met986Cys 9261097:76:99
status: NEW
view ABCB1 p.Met986Cys details
Fig. 1D shows that a product with reduced mobility on SDS-PAGE gels was present when mutants F343C/M986C, G346C/G989C, and P350C/ S993C were treated with oxidant. Login to comment
77 ABCB1 p.Pro350Cys
X
ABCB1 p.Pro350Cys 9261097:77:54
status: NEW
view ABCB1 p.Pro350Cys details
ABCB1 p.Ser993Cys
X
ABCB1 p.Ser993Cys 9261097:77:60
status: NEW
view ABCB1 p.Ser993Cys details
The highest level of cross-linking occurred in mutant P350C/S993C, since most of the protein migrated with reduced mobility after treatment with oxidant (Fig. 1D, lane 14). Login to comment
78 ABCB1 p.Leu339Cys
X
ABCB1 p.Leu339Cys 9261097:78:65
status: NEW
view ABCB1 p.Leu339Cys details
ABCB1 p.Val982Cys
X
ABCB1 p.Val982Cys 9261097:78:71
status: NEW
view ABCB1 p.Val982Cys details
ABCB1 p.Phe336Cys
X
ABCB1 p.Phe336Cys 9261097:78:49
status: NEW
view ABCB1 p.Phe336Cys details
ABCB1 p.Ser979Cys
X
ABCB1 p.Ser979Cys 9261097:78:55
status: NEW
view ABCB1 p.Ser979Cys details
No cross-linked product was observed for mutants F336C/S979C and L339C/V982C. Login to comment
80 ABCB1 p.Leu339Cys
X
ABCB1 p.Leu339Cys 9261097:80:36
status: NEW
view ABCB1 p.Leu339Cys details
ABCB1 p.Phe343Cys
X
ABCB1 p.Phe343Cys 9261097:80:49
status: NEW
view ABCB1 p.Phe343Cys details
ABCB1 p.Val991Cys
X
ABCB1 p.Val991Cys 9261097:80:86
status: NEW
view ABCB1 p.Val991Cys details
ABCB1 p.Phe335Cys
X
ABCB1 p.Phe335Cys 9261097:80:23
status: NEW
view ABCB1 p.Phe335Cys details
ABCB1 p.Leu976Cys
X
ABCB1 p.Leu976Cys 9261097:80:29
status: NEW
view ABCB1 p.Leu976Cys details
ABCB1 p.Ser979Cys
X
ABCB1 p.Ser979Cys 9261097:80:42
status: NEW
view ABCB1 p.Ser979Cys details
ABCB1 p.Phe983Cys
X
ABCB1 p.Phe983Cys 9261097:80:55
status: NEW
view ABCB1 p.Phe983Cys details
ABCB1 p.Ser351Cys
X
ABCB1 p.Ser351Cys 9261097:80:79
status: NEW
view ABCB1 p.Ser351Cys details
ABCB1 p.Ala987Cys
X
ABCB1 p.Ala987Cys 9261097:80:68
status: NEW
view ABCB1 p.Ala987Cys details
We also tested mutants F335C/L976C, L339C/S979C, F343C/F983C, G347C/A987C, and S351C/ V991C for cross-linking since they were predicted to lie on opposing faces of TM6 and TM12 modeled in a right-handed coiled-coil. Login to comment
82 ABCB1 p.Leu975Cys
X
ABCB1 p.Leu975Cys 9261097:82:144
status: NEW
view ABCB1 p.Leu975Cys details
ABCB1 p.Leu332Cys
X
ABCB1 p.Leu332Cys 9261097:82:138
status: NEW
view ABCB1 p.Leu332Cys details
Effect of Nucleotides and Drug Substrates on Cross-linking-An interesting observation was that the amount of cross-linking seen in mutant L332C/L975C in whole cells (9) varied with the metabolic state of the transfected cells. Login to comment
84 ABCB1 p.Leu975Cys
X
ABCB1 p.Leu975Cys 9261097:84:62
status: NEW
view ABCB1 p.Leu975Cys details
ABCB1 p.Leu332Cys
X
ABCB1 p.Leu332Cys 9261097:84:56
status: NEW
view ABCB1 p.Leu332Cys details
A possible explanation was that cross-linking of mutant L332C/L975C was promoted by the presence of ATP. Login to comment
91 ABCB1 p.Phe336Ser
X
ABCB1 p.Phe336Ser 9261097:91:20
status: NEW
view ABCB1 p.Phe336Ser details
ABCB1 p.Phe343Met
X
ABCB1 p.Phe343Met 9261097:91:54
status: NEW
view ABCB1 p.Phe343Met details
ABCB1 p.Leu339Val
X
ABCB1 p.Leu339Val 9261097:91:37
status: NEW
view ABCB1 p.Leu339Val details
ABCB1 p.Pro350Ser
X
ABCB1 p.Pro350Ser 9261097:91:92
status: NEW
view ABCB1 p.Pro350Ser details
The paired residues Phe-336/Ser-979, Leu-339/Val-982, Phe-343/Met-986, Gly-346/Gly-989, and Pro-350/Ser993 predicted to be close to each other (C, shaded circles) were replaced with cysteine and the mutant P-glycoproteins expressed in HEK 293 cells. Login to comment
96 ABCB1 p.Leu975Cys
X
ABCB1 p.Leu975Cys 9261097:96:22
status: NEW
view ABCB1 p.Leu975Cys details
ABCB1 p.Leu332Cys
X
ABCB1 p.Leu332Cys 9261097:96:16
status: NEW
view ABCB1 p.Leu332Cys details
pressing mutant L332C/L975C were cross-linked in the presence of nucleotides. Login to comment
99 ABCB1 p.Leu975Cys
X
ABCB1 p.Leu975Cys 9261097:99:59
status: NEW
view ABCB1 p.Leu975Cys details
ABCB1 p.Leu332Cys
X
ABCB1 p.Leu332Cys 9261097:99:49
status: NEW
view ABCB1 p.Leu332Cys details
These results suggest that cross-linking between L332C and L975C occurred during ATP hydrolysis. Login to comment
100 ABCB1 p.Gly346Cys
X
ABCB1 p.Gly346Cys 9261097:100:83
status: NEW
view ABCB1 p.Gly346Cys details
ABCB1 p.Gly989Cys
X
ABCB1 p.Gly989Cys 9261097:100:89
status: NEW
view ABCB1 p.Gly989Cys details
ABCB1 p.Pro350Cys
X
ABCB1 p.Pro350Cys 9261097:100:100
status: NEW
view ABCB1 p.Pro350Cys details
ABCB1 p.Ser993Cys
X
ABCB1 p.Ser993Cys 9261097:100:106
status: NEW
view ABCB1 p.Ser993Cys details
ABCB1 p.Phe343Cys
X
ABCB1 p.Phe343Cys 9261097:100:70
status: NEW
view ABCB1 p.Phe343Cys details
ABCB1 p.Met986Cys
X
ABCB1 p.Met986Cys 9261097:100:76
status: NEW
view ABCB1 p.Met986Cys details
The effect of nucleotides on cross-linking was also tested on mutants F343C/M986C, G346C/G989C, and P350C/S993C. Login to comment
103 ABCB1 p.Leu975Cys
X
ABCB1 p.Leu975Cys 9261097:103:70
status: NEW
view ABCB1 p.Leu975Cys details
ABCB1 p.Leu332Cys
X
ABCB1 p.Leu332Cys 9261097:103:64
status: NEW
view ABCB1 p.Leu332Cys details
ABCB1 p.Gly346Cys
X
ABCB1 p.Gly346Cys 9261097:103:90
status: NEW
view ABCB1 p.Gly346Cys details
ABCB1 p.Gly989Cys
X
ABCB1 p.Gly989Cys 9261097:103:96
status: NEW
view ABCB1 p.Gly989Cys details
ABCB1 p.Pro350Cys
X
ABCB1 p.Pro350Cys 9261097:103:107
status: NEW
view ABCB1 p.Pro350Cys details
ABCB1 p.Ser993Cys
X
ABCB1 p.Ser993Cys 9261097:103:114
status: NEW
view ABCB1 p.Ser993Cys details
ABCB1 p.Phe343Cys
X
ABCB1 p.Phe343Cys 9261097:103:77
status: NEW
view ABCB1 p.Phe343Cys details
ABCB1 p.Met986Cys
X
ABCB1 p.Met986Cys 9261097:103:83
status: NEW
view ABCB1 p.Met986Cys details
To test the effect of drug substrates, cross-linking of mutants L332C/L975C, F343C/M986C, G346C/G989C, and P350C/ S993C was done in the presence of verapamil, cyclosporin A, vinblastine, or colchicine. Login to comment
104 ABCB1 p.Leu975Cys
X
ABCB1 p.Leu975Cys 9261097:104:54
status: NEW
view ABCB1 p.Leu975Cys details
ABCB1 p.Leu332Cys
X
ABCB1 p.Leu332Cys 9261097:104:48
status: NEW
view ABCB1 p.Leu332Cys details
No cross-linked product was observed for mutant L332C/L975C (Fig. 3A). Login to comment
105 ABCB1 p.Gly346Cys
X
ABCB1 p.Gly346Cys 9261097:105:105
status: NEW
view ABCB1 p.Gly346Cys details
ABCB1 p.Gly989Cys
X
ABCB1 p.Gly989Cys 9261097:105:111
status: NEW
view ABCB1 p.Gly989Cys details
ABCB1 p.Pro350Cys
X
ABCB1 p.Pro350Cys 9261097:105:198
status: NEW
view ABCB1 p.Pro350Cys details
ABCB1 p.Ser993Cys
X
ABCB1 p.Ser993Cys 9261097:105:204
status: NEW
view ABCB1 p.Ser993Cys details
ABCB1 p.Phe343Cys
X
ABCB1 p.Phe343Cys 9261097:105:89
status: NEW
view ABCB1 p.Phe343Cys details
ABCB1 p.Met986Cys
X
ABCB1 p.Met986Cys 9261097:105:95
status: NEW
view ABCB1 p.Met986Cys details
By contrast, all the drug substrates were effective in blocking cross-linking of mutants F343C/M986C and G346C/G989C (Fig. 3, B and C), but were less effective in preventing cross-linking of mutant P350C/S993C (Fig. 3D). Login to comment
106 ABCB1 p.Pro350Cys
X
ABCB1 p.Pro350Cys 9261097:106:10
status: NEW
view ABCB1 p.Pro350Cys details
ABCB1 p.Ser993Cys
X
ABCB1 p.Ser993Cys 9261097:106:16
status: NEW
view ABCB1 p.Ser993Cys details
In mutant P350C/S993C, verapamil, cyclosporin A, and vinblastine were more effective than colchicine in inhibiting cross-linking. Login to comment
107 ABCB1 p.Leu339Cys
X
ABCB1 p.Leu339Cys 9261097:107:23
status: NEW
view ABCB1 p.Leu339Cys details
ABCB1 p.Val982Cys
X
ABCB1 p.Val982Cys 9261097:107:29
status: NEW
view ABCB1 p.Val982Cys details
ABCB1 p.Phe336Cys
X
ABCB1 p.Phe336Cys 9261097:107:14
status: NEW
view ABCB1 p.Phe336Cys details
ABCB1 p.Ser979Cys
X
ABCB1 p.Ser979Cys 9261097:107:8
status: NEW
view ABCB1 p.Ser979Cys details
Mutants S979C/F336C or L339C/V982C did not yield any cross-linked product even in the presence of ATP or drug substrates (data not shown). Login to comment
108 ABCB1 p.Leu975Cys
X
ABCB1 p.Leu975Cys 9261097:108:74
status: NEW
view ABCB1 p.Leu975Cys details
ABCB1 p.Leu332Cys
X
ABCB1 p.Leu332Cys 9261097:108:68
status: NEW
view ABCB1 p.Leu332Cys details
ABCB1 p.Gly346Cys
X
ABCB1 p.Gly346Cys 9261097:108:94
status: NEW
view ABCB1 p.Gly346Cys details
ABCB1 p.Gly989Cys
X
ABCB1 p.Gly989Cys 9261097:108:100
status: NEW
view ABCB1 p.Gly989Cys details
ABCB1 p.Pro350Cys
X
ABCB1 p.Pro350Cys 9261097:108:111
status: NEW
view ABCB1 p.Pro350Cys details
ABCB1 p.Ser993Cys
X
ABCB1 p.Ser993Cys 9261097:108:117
status: NEW
view ABCB1 p.Ser993Cys details
ABCB1 p.Phe343Cys
X
ABCB1 p.Phe343Cys 9261097:108:81
status: NEW
view ABCB1 p.Phe343Cys details
ABCB1 p.Met986Cys
X
ABCB1 p.Met986Cys 9261097:108:87
status: NEW
view ABCB1 p.Met986Cys details
Effect of Cross-linking on Drug-stimulated ATPase Activity- Mutants L332C/L975C, F343C/M986C, G346C/G989C, and P350C/S993C were still active since they retained about 90, 30, 10, and 70%, respectively, of the verapamil-stimulated ATPase activity of the Cys-less P-glycoprotein. Login to comment
109 ABCB1 p.Leu975Cys
X
ABCB1 p.Leu975Cys 9261097:109:82
status: NEW
view ABCB1 p.Leu975Cys details
ABCB1 p.Leu332Cys
X
ABCB1 p.Leu332Cys 9261097:109:76
status: NEW
view ABCB1 p.Leu332Cys details
ABCB1 p.Gly346Cys
X
ABCB1 p.Gly346Cys 9261097:109:38
status: NEW
view ABCB1 p.Gly346Cys details
ABCB1 p.Gly989Cys
X
ABCB1 p.Gly989Cys 9261097:109:44
status: NEW
view ABCB1 p.Gly989Cys details
ABCB1 p.Pro350Cys
X
ABCB1 p.Pro350Cys 9261097:109:55
status: NEW
view ABCB1 p.Pro350Cys details
ABCB1 p.Ser993Cys
X
ABCB1 p.Ser993Cys 9261097:109:61
status: NEW
view ABCB1 p.Ser993Cys details
ABCB1 p.Phe343Cys
X
ABCB1 p.Phe343Cys 9261097:109:25
status: NEW
view ABCB1 p.Phe343Cys details
ABCB1 p.Met986Cys
X
ABCB1 p.Met986Cys 9261097:109:31
status: NEW
view ABCB1 p.Met986Cys details
Cross-linking of mutants F343C/M986C, G346C/G989C, and P350C/S993C, but not L332C/L975C, was reversed by treatment with dithiothreitol (Fig. 4A). Login to comment
111 ABCB1 p.Pro350Cys
X
ABCB1 p.Pro350Cys 9261097:111:7
status: NEW
view ABCB1 p.Pro350Cys details
ABCB1 p.Ser993Cys
X
ABCB1 p.Ser993Cys 9261097:111:13
status: NEW
view ABCB1 p.Ser993Cys details
Mutant P350C/S993C was tested because it exhibited the greatest degree of cross-linking (Fig. 1D). Login to comment
112 ABCB1 p.Pro350Cys
X
ABCB1 p.Pro350Cys 9261097:112:20
status: NEW
view ABCB1 p.Pro350Cys details
ABCB1 p.Ser993Cys
X
ABCB1 p.Ser993Cys 9261097:112:26
status: NEW
view ABCB1 p.Ser993Cys details
In addition, mutant P350C/S993C had the highest activity of those mutants whose cross-linked products were sensitive to dithiothreitol. Login to comment
113 ABCB1 p.Pro350Cys
X
ABCB1 p.Pro350Cys 9261097:113:68
status: NEW
view ABCB1 p.Pro350Cys details
ABCB1 p.Ser993Cys
X
ABCB1 p.Ser993Cys 9261097:113:74
status: NEW
view ABCB1 p.Ser993Cys details
Membranes prepared from HEK 293 cells expressing Cys-less or mutant P350C/S993C P-glycoprotein- (His)10 were treated with or without 2 mM copper phenanthroline for 10 min at 37 °C. Login to comment
116 ABCB1 p.Pro350Cys
X
ABCB1 p.Pro350Cys 9261097:116:52
status: NEW
view ABCB1 p.Pro350Cys details
ABCB1 p.Ser993Cys
X
ABCB1 p.Ser993Cys 9261097:116:58
status: NEW
view ABCB1 p.Ser993Cys details
Fig. 4B (lane 4) shows that the cross-linked mutant P350C/S993C was also efficiently recovered, indicating that the histidine tag remained accessible after cross-linking. Login to comment
119 ABCB1 p.Pro350Cys
X
ABCB1 p.Pro350Cys 9261097:119:7
status: NEW
view ABCB1 p.Pro350Cys details
ABCB1 p.Ser993Cys
X
ABCB1 p.Ser993Cys 9261097:119:13
status: NEW
view ABCB1 p.Ser993Cys details
Mutant P350C/S993C, however, showed approximately 75% reduction of the verapamil-stimulated ATPase activity after cross-linking. Login to comment
121 ABCB1 p.Pro350Cys
X
ABCB1 p.Pro350Cys 9261097:121:84
status: NEW
view ABCB1 p.Pro350Cys details
ABCB1 p.Ser993Cys
X
ABCB1 p.Ser993Cys 9261097:121:94
status: NEW
view ABCB1 p.Ser993Cys details
This result suggested that dithiothreitol broke the disulfide bond between residues P350C and S993C and allowed movement to occur between TM6 and TM12 during drug-stimulated ATPase activity. Login to comment
124 ABCB1 p.Leu339Cys
X
ABCB1 p.Leu339Cys 9261097:124:54
status: NEW
view ABCB1 p.Leu339Cys details
ABCB1 p.Val982Cys
X
ABCB1 p.Val982Cys 9261097:124:60
status: NEW
view ABCB1 p.Val982Cys details
ABCB1 p.Phe336Cys
X
ABCB1 p.Phe336Cys 9261097:124:39
status: NEW
view ABCB1 p.Phe336Cys details
ABCB1 p.Ser979Cys
X
ABCB1 p.Ser979Cys 9261097:124:45
status: NEW
view ABCB1 p.Ser979Cys details
Cross-linking was not observed between F336C/S979C or L339C/V982C, even in the presence of ATP or drug substrates FIG. 2. Login to comment
126 ABCB1 p.Leu975Cys
X
ABCB1 p.Leu975Cys 9261097:126:63
status: NEW
view ABCB1 p.Leu975Cys details
ABCB1 p.Leu332Cys
X
ABCB1 p.Leu332Cys 9261097:126:57
status: NEW
view ABCB1 p.Leu332Cys details
ABCB1 p.Gly346Cys
X
ABCB1 p.Gly346Cys 9261097:126:91
status: NEW
view ABCB1 p.Gly346Cys details
ABCB1 p.Gly989Cys
X
ABCB1 p.Gly989Cys 9261097:126:97
status: NEW
view ABCB1 p.Gly989Cys details
ABCB1 p.Ser993Cys
X
ABCB1 p.Ser993Cys 9261097:126:117
status: NEW
view ABCB1 p.Ser993Cys details
ABCB1 p.Phe343Cys
X
ABCB1 p.Phe343Cys 9261097:126:74
status: NEW
view ABCB1 p.Phe343Cys details
ABCB1 p.Met986Cys
X
ABCB1 p.Met986Cys 9261097:126:80
status: NEW
view ABCB1 p.Met986Cys details
Membranes prepared from HEK 293 cells expressing mutants L332C/L975C (A), F343C/M986C (B), G346C/G989C (C), and P350/S993C (D) were treated without (-) or with (ϩ) 2 mM (A) or 0.2 mM (B-D) copper phenanthroline for 10 min at 37 °C in the presence of 5 mM ATP, 5 mM ATP plus 0.2 mM sodium vanadate, 5 mM ADP, 5 mM ADP plus 0.2 mM sodium vanadate, or 5 mM AMP-PNP. Login to comment
132 ABCB1 p.Leu975Cys
X
ABCB1 p.Leu975Cys 9261097:132:64
status: NEW
view ABCB1 p.Leu975Cys details
ABCB1 p.Leu332Cys
X
ABCB1 p.Leu332Cys 9261097:132:57
status: NEW
view ABCB1 p.Leu332Cys details
ABCB1 p.Gly346Cys
X
ABCB1 p.Gly346Cys 9261097:132:92
status: NEW
view ABCB1 p.Gly346Cys details
ABCB1 p.Gly989Cys
X
ABCB1 p.Gly989Cys 9261097:132:98
status: NEW
view ABCB1 p.Gly989Cys details
ABCB1 p.Ser993Cys
X
ABCB1 p.Ser993Cys 9261097:132:118
status: NEW
view ABCB1 p.Ser993Cys details
ABCB1 p.Phe343Cys
X
ABCB1 p.Phe343Cys 9261097:132:75
status: NEW
view ABCB1 p.Phe343Cys details
ABCB1 p.Met986Cys
X
ABCB1 p.Met986Cys 9261097:132:81
status: NEW
view ABCB1 p.Met986Cys details
Membranes prepared from HEK 293 cells expressing mutants L332C/ L975C (A), F343C/M986C (B), G346C/G989C (C), and P350/S993C (D) were treated without (-) or with (ϩ) 2 mM (A) or 0.2 mM (B-D) copper phenanthroline for 10 min at 37 °C in the presence of 1 mM verapamil, 0.1 mM vinblastine, 50 ␮M cyclosporin A, or 5 mM colchicine. Login to comment
140 ABCB1 p.Leu975Cys
X
ABCB1 p.Leu975Cys 9261097:140:95
status: NEW
view ABCB1 p.Leu975Cys details
ABCB1 p.Leu332Cys
X
ABCB1 p.Leu332Cys 9261097:140:88
status: NEW
view ABCB1 p.Leu332Cys details
ATP hydrolysis rather than nucleotide binding was responsible for cross-linking between L332C/ L975C. Login to comment
142 ABCB1 p.Leu975Cys
X
ABCB1 p.Leu975Cys 9261097:142:73
status: NEW
view ABCB1 p.Leu975Cys details
ABCB1 p.Leu975Cys
X
ABCB1 p.Leu975Cys 9261097:142:130
status: NEW
view ABCB1 p.Leu975Cys details
ABCB1 p.Leu332Cys
X
ABCB1 p.Leu332Cys 9261097:142:67
status: NEW
view ABCB1 p.Leu332Cys details
ABCB1 p.Leu332Cys
X
ABCB1 p.Leu332Cys 9261097:142:124
status: NEW
view ABCB1 p.Leu332Cys details
The observation that ATP hydrolysis promoted cross-linking between L332C/L975C suggests that inhibition of cross-linking of L332C/L975C in whole cells by verapamil or vinblastine occurred indirectly through depletion of intracellular ATP. Login to comment
144 ABCB1 p.Gly346Cys
X
ABCB1 p.Gly346Cys 9261097:144:65
status: NEW
view ABCB1 p.Gly346Cys details
ABCB1 p.Gly989Cys
X
ABCB1 p.Gly989Cys 9261097:144:71
status: NEW
view ABCB1 p.Gly989Cys details
ABCB1 p.Pro350Cys
X
ABCB1 p.Pro350Cys 9261097:144:82
status: NEW
view ABCB1 p.Pro350Cys details
ABCB1 p.Ser993Cys
X
ABCB1 p.Ser993Cys 9261097:144:88
status: NEW
view ABCB1 p.Ser993Cys details
ABCB1 p.Phe343Cys
X
ABCB1 p.Phe343Cys 9261097:144:51
status: NEW
view ABCB1 p.Phe343Cys details
ABCB1 p.Met986Cys
X
ABCB1 p.Met986Cys 9261097:144:58
status: NEW
view ABCB1 p.Met986Cys details
Drug substrates inhibited cross-linking of mutants F343C/ M986C, G346C/G989C, and P350C/S993C. Login to comment